Profitability Ratios
| Ratio |
Value |
| GP Margin |
76.2% |
| EBIT Margin |
-19.2% |
| EBITDA Margin |
-15.5% |
| Operating Margin |
-19.2% |
| Pretax Margin |
-34.4% |
| Cont. Ops Margin |
-33.6% |
| Net Margin |
-33.6% |
| Bottom Line Margin |
-33.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
4.55 |
| Quick Ratio |
3.74 |
| Solvency Ratio |
-0.611 |
| Cash Ratio |
2.24 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
-0.05 |
| Forward PEG |
-0.05 |
| Price/Book |
3.40 |
| Price/Sales |
4.89 |
| Price/FCF |
-29.21 |
| Price/Op Cash Flow |
-34.17 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0831 |
| Debt/Equity |
0.1114 |
| Debt/Capital |
0.1003 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
1.34 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.89 |
| Operating Cash Flow Ratio |
-0.500 |
| Operating Cash Flow/Sales |
-14.3% |
| Free Cash Flow/Operating Cash Flow |
117.0% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
0.00 |
| Interest Coverage |
0.0000 |
| Short-Term Operating Cash Flow Coverage |
0.00 |
| Operating Cash Flow Coverage |
-0.89 |
| Capital Expenditure Coverage |
-5.88 |
| Dividend + Capital Expenditure Coverage |
-5.88 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
4.83 |
| EPS |
-1.623 |
| Debt/Share |
0.7737 |
| Cash/Share |
3.78 |
| Book Value/Share |
6.94 |
| Tangible BV/Share |
6.29 |
| Equity/Share |
6.94 |
| Operating Cash Flow/Share |
-0.691 |
| Capital Expenditure/Share |
0.117 |
| FCF/Share |
-0.808 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.978 |
| Earnings Before Tax/EBIT |
1.790 |
| Price/Fair Value |
3.40 |
| Debt/Market Cap |
0.0000 |
| Effective Tax Rate |
2.2% |
| Enterprise Value Multiple |
-28.35 |
STAA - STAAR Surgical Company